In 2018, the predicted number of new breast cancers in 28 European Union (EU) countries
was 404 920, with estimated age-adjusted annual incidence of breast cancer of 144.9/100 …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Highlights•Breast cancer in young women should be treated based on stage and biology of
disease.•Management of breast cancer in young women requires special considerations …

In 2012, the estimated age-adjusted annual incidence of breast cancer in 40 European
countries was 94.2/100 000 and the mortality 23.1/100 000 [1]. The incidence increased …

Male breast cancer is a rare disease, of which little is known. In contrast to female breast
cancer, the very vast majority of all cases are positive for estrogen receptor alpha (ERα) …

Author links open overlay panel F. Cardoso a, A. Costa bc, L. Norton d, E. Senkus e, M.
Aapro f, F. André g, CH Barrios h, J. Bergh i, L. Biganzoli j, KL Blackwell k, MJ Cardoso l, T …

Purpose Genetic predisposition to male breast cancer (MBC) is not well understood. The
aim of this study was to better define the predisposition genes contributing to MBC and the …

Breast cancer is the leading cause of cancer in women in Spain and its annual incidence is
rapidly increasing. Thanks to the screening programs in place, nearly 90% of breast cancer …

Fluorouracil (5-FU)-induced intestinal mucositis (IM) is one of the most common oncological
problem. It involves serious clinical consequences such as diarrhea, erythematous lesions …

This text is based on the recommendations accepted by the 4th Hungarian Consensus
Conference on Breast Cancer, modified based on the international consultation and …